Ionis Pharmaceuticals, Inc.
Compositions and their uses directed to huntingtin
Last updated:
Abstract:
Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's disease progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntingtin's disease in an individual susceptible to Huntingtin's Disease. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
Status:
Grant
Type:
Utility
Filling date:
5 Oct 2017
Issue date:
11 Aug 2020